Probiotic peanut oral immunotherapy is associated with long‐term persistence of 8‐week sustained unresponsiveness and long‐lasting quality‐of‐life improvement-Reference-Cited by-同舟云学术

Probiotic peanut oral immunotherapy is associated with long‐term persistence of 8‐week sustained unresponsiveness and long‐lasting quality‐of‐life improvement

Published:2022-05-10 Issue:6 Volume:52 Page:806-811
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Experimental Allergy

Author:

Loke Paxton¹²³⁴^ORCID,Hsiao Kuang‐Chih¹⁵⁶^ORCID,Lozinsky Adriana Chebar¹^ORCID,Ashley Sarah E.¹²⁴^ORCID,Lloyd Melanie¹⁴,Pitkin Sigrid¹,Axelrad Christine Jean¹,Jayawardana Kaushala S.⁷,Tey Dean¹⁴,Su Ee Lyn¹⁴,Robinson Marnie¹⁴,Leung Agnes S.Y.¹⁸,Dunn Galvin Audrey⁹,Tang Mimi L.K.¹²⁴^ORCID

Affiliation:

1. Allergy Immunology Murdoch Children’s Research Institute Melbourne Victoria Australia

2. Department of Paediatrics University of Melbourne Melbourne Victoria Australia

3. Monash Children’s Hospital Melbourne Victoria Australia

4. Department of Allergy and Immunology Royal Children’s Hospital Melbourne Victoria Australia

5. Department of Immunology Starship Children's Hospital Auckland New Zealand

6. Department of Paediatrics University of Auckland Auckland New Zealand

7. Centre for Biostatistics and Epidemiology Murdoch Children’s Research Institute Melbourne Victoria Australia

8. Department of Paediatrics Prince of Wales Hospital The Chinese University of Hong Kong Hong Kong Hong Kong

9. School of Applied Psychology University College Cork Cork City Ireland

Funder

Murdoch Children's Research Institute

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.14137

Reference9 articles.

1. Community-Based Adverse Food Reactions and Anaphylaxis in Children with IgE-Mediated Food Allergy at Age 6 Years: A Population-Based Study

2. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study

3. Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety

4. Administration of a probiotic with peanut oral immunotherapy: A randomized trial

5. Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two‐year post‐treatment outcomes following peanut oral immunotherapy in the Probiotic and Peanut Oral Immunotherapy‐003 Long‐Term (PPOIT‐003LT) study;Allergy;2024-08-04

2. Food allergy yardstick;Annals of Allergy, Asthma & Immunology;2024-08

3. The Immunobiology and Treatment of Food Allergy;Annual Review of Immunology;2024-06-28

4. Oral immunotherapy using boiled peanuts for treating peanut allergy: An open‐label, single‐arm trial;Clinical & Experimental Allergy;2023-01-11

5. Food Allergy and Eosinophilic Gastrointestinal Diseases—The Next 10 Years;The Journal of Allergy and Clinical Immunology: In Practice;2023-01